JP2020532302A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020532302A5 JP2020532302A5 JP2020512530A JP2020512530A JP2020532302A5 JP 2020532302 A5 JP2020532302 A5 JP 2020532302A5 JP 2020512530 A JP2020512530 A JP 2020512530A JP 2020512530 A JP2020512530 A JP 2020512530A JP 2020532302 A5 JP2020532302 A5 JP 2020532302A5
- Authority
- JP
- Japan
- Prior art keywords
- glucocorticoids
- glucocorticoid
- administration
- humans
- trait score
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003862 glucocorticoid Substances 0.000 claims 25
- 229940037128 systemic glucocorticoids Drugs 0.000 claims 13
- 238000000034 method Methods 0.000 claims 11
- 241000282412 Homo Species 0.000 claims 9
- 230000002068 genetic effect Effects 0.000 claims 8
- 239000008280 blood Substances 0.000 claims 7
- 210000004369 blood Anatomy 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 101100107081 Danio rerio zbtb16a gene Proteins 0.000 claims 4
- 102100037573 Dual specificity protein phosphatase 12 Human genes 0.000 claims 4
- 102100030880 Enoyl-CoA hydratase domain-containing protein 3, mitochondrial Human genes 0.000 claims 4
- 101000924017 Homo sapiens Dual specificity protein phosphatase 1 Proteins 0.000 claims 4
- 101000881110 Homo sapiens Dual specificity protein phosphatase 12 Proteins 0.000 claims 4
- 101000919891 Homo sapiens Enoyl-CoA hydratase domain-containing protein 3, mitochondrial Proteins 0.000 claims 4
- 101001077600 Homo sapiens Insulin receptor substrate 2 Proteins 0.000 claims 4
- 101001076422 Homo sapiens Interleukin-1 receptor type 2 Proteins 0.000 claims 4
- 101000977768 Homo sapiens Interleukin-1 receptor-associated kinase 3 Proteins 0.000 claims 4
- 101000799318 Homo sapiens Long-chain-fatty-acid-CoA ligase 1 Proteins 0.000 claims 4
- 101000878253 Homo sapiens Peptidyl-prolyl cis-trans isomerase FKBP5 Proteins 0.000 claims 4
- 101100377226 Homo sapiens ZBTB16 gene Proteins 0.000 claims 4
- 102100025092 Insulin receptor substrate 2 Human genes 0.000 claims 4
- 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 claims 4
- 102100023530 Interleukin-1 receptor-associated kinase 3 Human genes 0.000 claims 4
- 102100033995 Long-chain-fatty-acid-CoA ligase 1 Human genes 0.000 claims 4
- 102100037026 Peptidyl-prolyl cis-trans isomerase FKBP5 Human genes 0.000 claims 4
- 108700003766 Promyelocytic Leukemia Zinc Finger Proteins 0.000 claims 4
- 102100040314 Zinc finger and BTB domain-containing protein 16 Human genes 0.000 claims 4
- 230000014509 gene expression Effects 0.000 claims 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims 2
- 229960005205 prednisolone Drugs 0.000 claims 2
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 2
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 claims 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 claims 1
- 102100021763 Alpha-mannosidase 2x Human genes 0.000 claims 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 claims 1
- 102100034799 CCAAT/enhancer-binding protein delta Human genes 0.000 claims 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 claims 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 claims 1
- 102100038688 Cysteine-rich secretory protein LCCL domain-containing 2 Human genes 0.000 claims 1
- 102100029595 Fatty acyl-CoA reductase 2 Human genes 0.000 claims 1
- 102100028761 Heat shock 70 kDa protein 6 Human genes 0.000 claims 1
- 101000615966 Homo sapiens Alpha-mannosidase 2x Proteins 0.000 claims 1
- 101000945965 Homo sapiens CCAAT/enhancer-binding protein delta Proteins 0.000 claims 1
- 101000957715 Homo sapiens Cysteine-rich secretory protein LCCL domain-containing 2 Proteins 0.000 claims 1
- 101000917301 Homo sapiens Fatty acyl-CoA reductase 2 Proteins 0.000 claims 1
- 101001078680 Homo sapiens Heat shock 70 kDa protein 6 Proteins 0.000 claims 1
- 101000652382 Homo sapiens O-phosphoseryl-tRNA(Sec) selenium transferase Proteins 0.000 claims 1
- 101000583616 Homo sapiens Polyhomeotic-like protein 2 Proteins 0.000 claims 1
- 101000823949 Homo sapiens Serine palmitoyltransferase 2 Proteins 0.000 claims 1
- 101000689199 Homo sapiens Src-like-adapter Proteins 0.000 claims 1
- 101000596277 Homo sapiens TSC22 domain family protein 3 Proteins 0.000 claims 1
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 claims 1
- 102100030903 Polyhomeotic-like protein 2 Human genes 0.000 claims 1
- 102100022059 Serine palmitoyltransferase 2 Human genes 0.000 claims 1
- 102100024519 Src-like-adapter Human genes 0.000 claims 1
- 102100035260 TSC22 domain family protein 3 Human genes 0.000 claims 1
- 102100024333 Toll-like receptor 2 Human genes 0.000 claims 1
- 229960002537 betamethasone Drugs 0.000 claims 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 claims 1
- 229960004436 budesonide Drugs 0.000 claims 1
- 229960004544 cortisone Drugs 0.000 claims 1
- 229960003957 dexamethasone Drugs 0.000 claims 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims 1
- 229960002714 fluticasone Drugs 0.000 claims 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 claims 1
- 229960000890 hydrocortisone Drugs 0.000 claims 1
- 229960004584 methylprednisolone Drugs 0.000 claims 1
- 229960005294 triamcinolone Drugs 0.000 claims 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762551839P | 2017-08-30 | 2017-08-30 | |
| US62/551,839 | 2017-08-30 | ||
| PCT/US2018/048240 WO2019046233A1 (en) | 2017-08-30 | 2018-08-28 | METHOD FOR MONITORING PHARMACODYNAMIC RESPONSES MEDIATED BY IN VIVO DELIVERY OF GLUCOCORTICOIDS |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020532302A JP2020532302A (ja) | 2020-11-12 |
| JP2020532302A5 true JP2020532302A5 (cg-RX-API-DMAC7.html) | 2021-08-19 |
| JP7288431B2 JP7288431B2 (ja) | 2023-06-07 |
Family
ID=63678673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020512530A Active JP7288431B2 (ja) | 2017-08-30 | 2018-08-28 | グルココルチコイドのインビボ投与によって介在される薬力学的応答をモニタリングするための方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11421278B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3676402B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7288431B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102736851B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111051534B (cg-RX-API-DMAC7.html) |
| ES (1) | ES2971091T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019046233A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113990486B (zh) * | 2021-10-27 | 2025-08-22 | 北京博富瑞医学检验实验室有限公司 | 一种基于aGVHD biomarker的一线糖皮质激素治疗反应预测模型 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003016493A2 (en) * | 2001-08-17 | 2003-02-27 | Incyte Genomics, Inc. | Transporters and ion channels |
| US7384736B2 (en) * | 2001-09-06 | 2008-06-10 | Decode Genetics Ehf. | Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease |
| CN1193761C (zh) * | 2003-06-25 | 2005-03-23 | 暨南大学 | 一种糖皮质激素的可控释放体系及其制备方法 |
| SE0401032D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new acute glucocorticoid therapy |
| WO2006027786A2 (en) * | 2004-09-09 | 2006-03-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Use of liposomal glucocorticoids for treating inflammatory states |
| SMT201700250T1 (it) * | 2010-11-10 | 2017-07-18 | Amgen Res Munich Gmbh | Prevenzione di effetti avversi provocati da domini leganti cd3 specifici |
| WO2013082288A1 (en) * | 2011-11-29 | 2013-06-06 | The Regents Of The University Of California | Glucorticoid receptor gene nr3c1 methylation in irritable bowel syndrome and other stress disorders |
-
2018
- 2018-08-28 JP JP2020512530A patent/JP7288431B2/ja active Active
- 2018-08-28 US US16/642,060 patent/US11421278B2/en active Active
- 2018-08-28 KR KR1020207008663A patent/KR102736851B1/ko active Active
- 2018-08-28 ES ES18773895T patent/ES2971091T3/es active Active
- 2018-08-28 CN CN201880056618.6A patent/CN111051534B/zh active Active
- 2018-08-28 WO PCT/US2018/048240 patent/WO2019046233A1/en not_active Ceased
- 2018-08-28 EP EP18773895.0A patent/EP3676402B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kicic et al. | Decreased fibronectin production significantly contributes to dysregulated repair of asthmatic epithelium | |
| Arão et al. | Increased miRNA-146a and miRNA-155 expressions in oral lichen planus | |
| Tessier et al. | BAL in children: a controlled study of differential cytology and cytokine expression profiles by alveolar cells in pediatric sarcoidosis | |
| Mohamed et al. | Influence of glucocorticoid receptor gene NR3C1 646 C> G polymorphism on glucocorticoid resistance in asthmatics: a preliminary study | |
| JP2020532302A5 (cg-RX-API-DMAC7.html) | ||
| Mubark et al. | Evaluation gene expression of long non-coding RNA and 5-hydroxytriptamine 3A receptor in bronchial asthma | |
| EP4076671A4 (en) | Novel druggable targets for the treatment of inflammatory diseases such as systemic lupus erythematosus (sle) and methods for diagnosis and treatment using the same | |
| EP3676402B1 (en) | A method to monitor pharmacodynamic responses mediated by in vivo administration of glucocorticoids | |
| CN106591484B (zh) | 一种基于hsp90b1基因多态性位点基因型预测糖皮质激素治疗sle疗效的用途和试剂盒 | |
| WO2023288130A1 (en) | Methods of detecting sjögren's syndrome using salivary exosomes | |
| Salah et al. | Association between glucocorticosteroid receptor (NR3C1) gene polymorphism and bronchial asthma in children | |
| Nguyen et al. | Distinguishing Molecular Phenotypes in Severe Asthma Using Genomic Signatures of the Airway Epithelial Inflammatory Response in the Severe Asthma Research Program | |
| Mishra et al. | DECIPHER ROLE OF CLASS-1 HDACS ON P-GP EXPRESSION IN BRONCHIAL ASTHMA | |
| EP3619320B1 (en) | Predictive response biomarkers to glucocorticosteroids | |
| Dhesi et al. | S90 The effect of long acting beta-agonists on glucocorticoid receptor and importin-7 nuclear translocation in airway smooth muscle cells | |
| Lachowicz-Scroggins et al. | C33 CYTOKINES AND ASTHMA MEDIATORS: Characterization Of Airway Ormdl3 Expression In Human Asthma And In Relation To The Asthma Gwas Variant Rs7216389 | |
| Rendini et al. | Leprosy is teaching us the immunopathogenesis of inflammatory skin disease | |
| Cosentino et al. | Clinical Outcomes And Disease Progression In Patients With Asthma-COPD Overlap Syndrome | |
| Schüller et al. | The ecNOS gene in allergic Czech children. | |
| Everman et al. | Functional Exploration Of The Cdhr3 Asthma Risk Gene By Crispr-Cas9 Gene Knockout In Primary Airway Epithelium | |
| JP2016065006A5 (cg-RX-API-DMAC7.html) | ||
| Faiz et al. | Meta-Analysis and Functional Validation of Genes Altered by Corticosteroid Treatment Using a CRISPR-Cas9 Knockout Model | |
| Fahmy et al. | P2. 57 First dysferlinopathy patients in Egypt: Clinical, pathological and genetic characteristics | |
| Emberlin et al. | Nasal Application of Powder vs. Liquid Cellulose Derivatives to Suppress Allergen Challenge | |
| Ahmet | Adrenal suppression: 19 case reports |